During the third quarter, Altrius Capital Management Inc increased its holdings in Procter & Gamble by 11.7%, acquiring an additional 3,320 shares to bring its total to 31,660 shares. At the end of the period, the firm’s Procter & Gamble position was valued at $4.87 million. This move reflects growing confidence in the company’s resilience and cash-flow generation, and follows a broader trend of institutional investors allocating more to consumer staples names this fiscal year.

Several other investment managers also adjusted their Procter & Gamble positions in the past two quarters. Orca Investment Management added 64 shares to reach 3,238 shares, Sovereign Financial Group bought 65 shares to hold 5,823 shares, WP Advisors increased its stake by 66 shares to 1,405 shares, Emprise Bank added 68 shares to total 2,766 shares, and Brucke Financial acquired 69 shares to reach 2,310 shares. Collectively, these transactions contribute to the 65.8% of Procter & Gamble stock held by institutional investors and underscore steady, incremental interest from diversified asset managers.

In recent months, Jefferies upgraded the stock from hold to buy and raised its target from $156 to $179, while UBS increased its target from $161 to $170 and reiterated a buy recommendation. Morgan Stanley set an objective of $175 and Deutsche Bank maintained a buy view with a revised target of $171. Among the 22 analysts covering the company, 13 recommend buy and nine recommend hold, yielding a consensus moderate-buy stance and an average target of $167. These revisions reflect optimism about the firm’s pricing power, brand equity, and margin stability.

In its latest quarter, Procter & Gamble reported adjusted earnings per share of $1.88, exceeding consensus by $0.02, on revenue of $22.21 billion, with top-line growth of 1.5% year-over-year. Net margin stood at 19.3% and return on equity at 32.2%. The company announced a quarterly dividend of $1.0568 per share, implying an annualized payout of $4.23 and a yield of approximately 2.7%, with a payout ratio near 63%. Management reiterated its full-year EPS guidance range of 6.83 to 7.09, signaling steady cash return potential and defensive characteristics for investors seeking income and stability.